nach oben

Erschienen in:

25.09.2017 | Review Paper

Screening for Behavioral Health Conditions in Primary Care Settings: A Systematic Review of the Literature

verfasst von: Norah Mulvaney-Day, PhD, Tina Marshall, PhD, Kathryn Downey Piscopo, PhD, Neil Korsen, MD, MS, Sean Lynch, PhD, LCSW, Lucy H. Karnell, PhD, Garrett E. Moran, PhD, Allen S. Daniels, EdD, Sushmita Shoma Ghose, PhD

Erschienen in: Journal of General Internal Medicine | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Mounting evidence indicates that early recognition and treatment of behavioral health disorders can prevent complications, improve quality of life, and help reduce health care costs. The aim of this systematic literature review was to identify and evaluate publicly available, psychometrically tested tools that primary care physicians (PCPs) can use to screen adult patients for common mental and substance use disorders such as depression, anxiety, and alcohol use disorders.

Methods

We followed the Institute of Medicine (IOM) systematic review guidelines and searched PubMed, PsycINFO, Applied Social Sciences Index and Abstracts, Cumulative Index to Nursing and Allied Health Literature, and Health and Psychosocial Instruments databases to identify literature addressing tools for screening of behavioral health conditions. We gathered information on each tool’s psychometrics, applicability in primary care, and characteristics such as number of items and mode of administration. We included tools focused on adults and the most common behavioral health conditions; we excluded tools designed for children, youth, or older adults; holistic health scales; and tools screening for serious but less frequently encountered disorders, such as bipolar disorder.

Results

We identified 24 screening tools that met the inclusion criteria. Fifteen tools were subscales stemming from multiple-disorder assessments or tools that assessed more than one mental disorder or more than one substance use disorder in a single instrument. Nine were ultra-short, single-disorder tools. The tools varied in psychometrics and the extent to which they had been administered and studied in primary care settings.

Discussion

Tools stemming from the Patient Health Questionnaire had the most testing and application in primary care settings. However, numerous other tools could meet the needs of primary care practices. This review provides information that PCPs can use to select appropriate tools to incorporate into a screening protocol.

Talen MR, Baumer JG, Mann MM. Screening measures in integrated behavioral health and primary care settings. In: Talen MR, Valeras B, eds. Integrated behavioral health in primary care: evaluating the evidence, identifying the essentials. New York, NY: Springer Science + Business Media, 2013.CrossRef

Mertens JR, Lu YW, Parthasarathy S, Moore C, Weisner CM. Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls. Arch Intern Med. 2003;163(20):2511–2517. https://doi.org/10.1001/archinte.163.20.2511.CrossRefPubMed

U.S. Preventive Services Task Force. Recommendations for primary care practice. Available at: https://www.uspreventiveservicestaskforce.org/BrowseRec/Index/browse-recommendations. Accessed July 18, 2017.

Siu AL, Bibbins-Domingo K, Grossman DC, et al. Screening for depression in adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;315(4):380–387. https://doi.org/10.1001/jama.2015.18392.CrossRefPubMed

Harrison DL, Miller MJ, Schmitt MR, Touchet BK. Variations in the probability of depression screening at community-based physician practice visits. Prim Care Companion J Clin Psychiatry. 2010;12(5). https://doi.org/10.4088/PCC.09m00911blu.

Miller BF, Talen MR, Patel KK. Advancing integrated behavioral health and primary care: the critical importance of behavioral health in health care policy. In Talen MR, Valeras AB, eds. Integrated behavioral health in primary care: evaluating the evidence, identifying the essentials. New York, NY: Springer Science + Business Media, 2013.

RTI International. Accountable Care Organization 2015 Program Analysis Quality Performance Standards Narrative Measure Specifications. RTI; 2015. Available at: https://www.cms.gov/medicare/medicare-fee-for-service-payment/sharedsavingsprogram/downloads/ry2015-narrative-specifications.pdf. Accessed August 6, 2017.

Fiellin DA, Reid MC, O’Connor PG. Screening for alcohol problems in primary care: a systematic review. Arch Intern Med. 2000;160(13):1977–1989.CrossRefPubMed

Lakkis NA, Mahmassani DM. Screening instruments for depression in primary care: a concise review for clinicians. Postgrad Med. 2015;127(1):99–106. https://doi.org/10.1080/00325481.2015.992721.CrossRefPubMed

10.

Kroenke K, Monahan PO, Kean J. Pragmatic characteristics of patient-reported outcome measures are important for use in clinical practice. J Clin Epidemiol. 2015;68(9):1085–1092. https://doi.org/10.1016/j.jclinepi.2015.03.023.CrossRefPubMedPubMedCentral

11.

Schmitt MR, Miller MJ, Harrison DL, Touchet BK. Relationship of depression screening and physician office visit duration in a national sample. Psychiatr Serv. 2010;61(11):1126–1131. https://doi.org/10.1176/ps.2010.61.11.1126 CrossRefPubMed

12.

Korsen N. Translating a guideline into practice: the USPSTF recommendations on screening for depression in adults. Am Fam Physician. 2010;82(8):891.PubMed

13.

Finding what works in health care: Standards for systematic reviews. Institute of Medicine. 2011. Available at: http://iom.nationalacademies.org/Reports/2011/Finding-What-Works-in-Health-Care-Standards-for-Systematic-Reviews/Standards.aspx. Accessed July 18, 2017.

14.

Takwoingi Y, Riley RD, Deeks JJ. Meta-analysis of diagnostic accuracy studies in mental health. Evid Based Ment Health. 2015;18(4):103–109. https://doi.org/10.1136/eb-2015-102228.CrossRefPubMedPubMedCentral

15.

Mitchell AJ, Coyne JC. Do ultra-short screening instruments accurately detect depression in primary care? A pooled analysis and meta-analysis of 22 studies. Br J Gen Pract. 2007;57(535):144–151.PubMedPubMedCentral

16.

Kocalevent RD, Hinz A, Brahler E. Standardization of a screening instrument (PHQ-15) for somatization syndromes in the general population. BMC Psychiatry. 2013;13:91. https://doi.org/10.1186/1471-244X-13-91.CrossRefPubMedPubMedCentral

17.

van Ravesteijn H, Wittkampf K, Lucassen P, et al. Detecting somatoform disorders in primary care with the PHQ-15. Ann Fam Med. 2009;7(3):232–238. https://doi.org/10.1370/afm.985.CrossRefPubMedPubMedCentral

18.

Interian A, Allen LA, Gara MA, Escobar JI, Diaz-Martinez AM. Somatic complaints in primary care: further examining the validity of the Patient Health Questionnaire (PHQ-15). Psychosomatics. 2006;47(5):392–398. https://doi.org/10.1176/appi.psy.47.5.392.CrossRefPubMed

19.

Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613.CrossRefPubMedPubMedCentral

20.

Arroll B, Goodyear-Smith F, Crengle S, et al. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med. 2010;8(4),348–353. https://doi.org/10.1370/afm.1139.CrossRefPubMedPubMedCentral

21.

Ebell MH. Screening instruments for depression. Am Fam Physician. 2008;78(2):244–246.PubMed

22.

Kroenke K, Spitzer RL, Williams JB, Lowe B. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry. 2010;32(4):345–359. https://doi.org/10.1016/j.genhosppsych.2010.03.006.CrossRefPubMed

23.

Gjerdingen D, Crow S, McGovern P, Miner M, Center B. Postpartum depression screening at well-child visits: validity of a 2-question screen and the PHQ-9. Ann Fam Med. 2009;7(1):63–70. https://doi.org/10.1370/afm.933.CrossRefPubMedPubMedCentral

24.

Huang FY, Chung H, Kroenke K, Delucchi KL, Spitzer RL. Using the Patient Health Questionnaire-9 to measure depression among racially and ethnically diverse primary care patients. J Gen Intern Med. 2006;21(6):547–552. https://doi.org/10.1111/j.1525-1497.2006.00409.x.CrossRefPubMedPubMedCentral

25.

Uebelacker, LA, German, NM, Gaudiano, BA, Miller, IW. Patient Health Questionnaire depression scale as a suicide screening instrument in depressed primary care patients: a cross-sectional study. Prim Care Companion CNS Disord. 2011;13. doi:https://doi.org/10.4088/PCC.10m01027.

26.

Smits N, Finkelman MD. Shortening the PHQ-9: A proof-of-principle study of utilizing Stochastic Curtailment as a method for constructing ultrashort screening instruments. Gen Hosp Psychiatry. 2015;37(5):464–469. https://doi.org/10.1016/j.genhosppsych.2015.04.011.CrossRefPubMed

27.

Benjamin S, Herr NR, McDuffie J, Nagi A, Williams JW. Performance characteristics of self-report instruments for diagnosing generalized anxiety and panic disorders in primary care: A systematic review. Department of Veterans Affairs. 2011. http://www.hsrd.research.va.gov/publications/esp/anxiety-panic.cfm.

28.

Lowe B, Decker O, Muller S, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008;46(3):266–274. https://doi.org/10.1097/MLR.0b013e318160d093.CrossRefPubMed

29.

Delgadillo J, Payne S, Gilbody S, et al. Brief case finding tools for anxiety disorders: Validation of GAD-7 and GAD-2 in addictions treatment. Drug Alcohol Depend. 2012;125(1–2):37–42. https://doi.org/10.1016/j.drugalcdep.2012.03.011.CrossRefPubMed

30.

Lowe B, Wahl I, Rose M, et al. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord. 2010;122(1–2):86–95. https://doi.org/10.1016/j.jad.2009.06.019.CrossRefPubMed

31.

Kroenke K, Spitzer RL, Williams JB, Lowe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009;50(6):613–621. https://doi.org/10.1176/appi.psy.50.6.613/.PubMed

32.

Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41(11):1284–1292. https://doi.org/10.1097/01.MLR.0000093487.78664.3C.CrossRefPubMed

33.

Kroenke K, Spitzer RL, Williams JB, Monahan PO, Lowe B. Anxiety disorders in primary care: Prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317–325.CrossRefPubMed

34.

Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction. 1993;88(6):791–804.CrossRefPubMed

35.

Chan-Pensley E. Alcohol-Use Disorders Identification Test: A comparison between paper and pencil and computerized versions. Alcohol Alcohol. 1999;34(6),882–885.CrossRefPubMed

36.

Kypri K, Saunders JB, Williams SM, et al. Web-based screening and brief intervention for hazardous drinking: a double-blind randomized controlled trial. Addiction. 2004;99(11):1410–1417. https://doi.org/10.1111/j.1360-0443.2004.00847.x.CrossRefPubMed

37.

Allen JP, Reinert DF, Volk RJ. The alcohol use disorders identification test: an aid to recognition of alcohol problems in primary care patients. Prev Med. 2001;33(5):428–433. https://doi.org/10.1006/pmed.2001.0910.CrossRefPubMed

38.

Rao R. Alcohol use disorders identification test has bias. BMJ. 2006;332(7542):667–668. https://doi.org/10.1136/bmj.332.7542.667-b.CrossRefPubMedPubMedCentral

39.

Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, Frank D, Kivlahan DR. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res. 2007;31(7),1208–1217. https://doi.org/10.1111/j.1530-0277.2007.00403.CrossRefPubMed

40.

Kaarne T, Aalto M, Kuokkanen M, Seppa K. AUDIT-C, AUDIT-3 and AUDIT-QF in screening risky drinking among Finnish occupational health-care patients. Drug Alcohol Rev. 2010;29(5):563–567. https://doi.org/10.1111/j.1465-3362.2010.00172.x.CrossRefPubMed

41.

Screener overview. Available at: http://www.phqscreeners.com/select-screener. Accessed July 18, 2017.

42.

Fuchs CH, Haradhvala N, Hubley S, et al. Physician actions following a positive PHQ-2: implications for the implementation of depression screening in family medicine practice. Fam Syst Health. 2015;33(1):18–27. https://doi.org/10.1037/fsh0000089.CrossRefPubMed

43.

Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: An updated literature review. J Psychosom Res. 2002;52(2):69–77.CrossRefPubMed

44.

Lowe B, Kroenke K, Herzog W, Grafe K. Measuring depression outcome with a brief self-report instrument: Sensitivity to change of the Patient Health Questionnaire (PHQ-9). J Affect Disord. 2004;81(8):61–66. https://doi.org/10.1016/S0165-0327(03)00198-8.CrossRefPubMed

45.

Farvolden P, McBride C, Bagby RM, Ravitz P. A web-based screening instrument for depression and anxiety disorders in primary care. J Med Internet Res. 2003;5(3):e23. https://doi.org/10.2196/jmir.5.3.e23.CrossRefPubMedPubMedCentral

46.

Kellogg SH, McHugh PF, Bell K, et al. The Kreek-McHugh-Schluger-Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications. Drug Alcohol Depend. 2003;69(2):137–150.CrossRefPubMed

47.

Tang YL, Khoury L, Bradley B, Gillespie CF, Ressler KJ, Cubells JF. Substance use disorders assessed using the Kreek-McHugh-Schluger-Kellogg (KMSK) scale in an urban low-income and predominantly African American sample of primary care patients. Am J Addict. 2011;20(3):292–299. https://doi.org/10.1111/j.1521-0391.2011.00121.x.CrossRefPubMedPubMedCentral

48.

Jamison RN, Serraillier J, Michna E. Assessment and treatment of abuse risk in opioid prescribing for chronic pain. Pain Res Treat. 2011;2011:941808. https://doi.org/10.1155/2011/941808.PubMedPubMedCentral

49.

McPherson TL, Hersch RK. Brief substance use screening instruments for primary care settings: a review. J Subst Abuse Treat. 2000;18(2):193–202.CrossRefPubMed

50.

Maisto SA, Carey MP, Carey KB, Gordon CM, Gleason JR. Use of the AUDIT and the DAST-10 to identify alcohol and drug use disorders among adults with a severe and persistent mental illness. Psychol Assess. 2000;12(2):186–192.CrossRefPubMed

51.

Yudko E, Lozhkina O, Fouts A. A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. J Subst Abuse Treat. 2007;32(2):189–198.CrossRefPubMed

52.

Saltstone R, Halliwell S, Hayslip MA. A multivariate evaluation of the Michigan alcoholism screening test and the drug abuse screening test in a female offender population. Addict Behav. 1994;19(5):455–462.CrossRefPubMed

53.

McNeely J, Wu LT, Subramaniam G, et al. Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) tool for screening in primary care patients. Ann Intern Med. 2016;165(10) 690–699. https://doi.org/10.7326/M16-0317.CrossRefPubMedPubMedCentral

54.

Gryczynski J, McNeely J, Wu LT, et al. Validation of the TAPS-1: a four-item screening tool to identify unhealthy substance use in primary care. J Gen Intern Med 2017. https://doi.org/10.1007/s11606-017-4079-x.

55.

Humeniuk R, Ali R. Validation of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) With Pilot Brief Intervention: a Technical Report of Phase II Findings of the WHO ASSIST Project. World Health Organization; 2006. http://www.who.int/substance_abuse/activities/assist_technicalreport_phase2_final.pdf?ua=1.

56.

Lee JD, Delbanco B, Wu E, Gourevitch MN. Substance use prevalence and screening instrument comparisons in urban primary care. Subst Abus. 2011;32(3):128–134. https://doi.org/10.1080/08897077.2011.562732.CrossRefPubMed

57.

McNeely J, Strauss SM, Wright S, et al. Test-retest reliability of a self-administered Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in primary care patients. J Subst Abuse Treat. 2014;47(1):93–101. https://doi.org/10.1016/j.jsat.2014.01.007.CrossRefPubMedPubMedCentral

58.

Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J. Screening, Brief Intervention, and Referral to Treatment (SBIRT): Toward a public health approach to the management of substance abuse. Subst Abus. 2007;28(3),7–30. https://doi.org/10.1300/J465v28n03_03.CrossRefPubMed

59.

National Institute on Drug Abuse. Screening for drug use in medical settings. NIDA. 2010. Available at: http://www.drugabuse.gov/publications/resource-guide/preface. Accessed August 6, 2017.

60.

Spear SE, Shedlin M, Gilberti B, Fiellin M, McNeely J. Feasibility and acceptability of an Audio Computer-Assisted Self-Interview version of the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) in primary care patients. Subst Abus. 2015;37(2):299–305. https://doi.org/10.1080/08897077.2015.1062460.CrossRef

61.

Means-Christensen AJ, Arnau RC, Tonidandel AM, Bramson R, Meagher MW. An efficient method of identifying major depression and panic disorder in primary care. J Behav Med. 2005;28(6):565–572. https://doi.org/10.1007/s10865-005-9023-6.CrossRefPubMed

62.

Hsu GLK, Wan YM, Adler D, Rand W, Choi E, Tsang BYP. Detection of major depressive disorder in Chinese Americans in primary care. Hong Kong Journal of Psychiatry. 2005;15(3):71–76.

63.

Henkel V, Mergl R, Kohnen R, Maier W, Moller HJ, Hegerl U. Identifying depression in primary care: a comparison of different methods in a prospective cohort study. BMJ. 2003; 326(7382),200–201.CrossRefPubMedPubMedCentral

64.

Saipanish R, Lotrakul M, Sumrithe S. Reliability and validity of the Thai version of the WHO-Five Well-Being Index in primary care patients. Psychiatry Clin Neurosci. 2009;63(2):141–146. https://doi.org/10.1111/j.1440-1819.2009.01933.x.CrossRefPubMed

65.

Jefford M, Mileshkin L, Richards K, et al. Rapid screening for depression–validation of the Brief Case-Find for Depression (BCD) in medical oncology and palliative care patients. Br J Cancer. 2004;91(5):900–906. https://doi.org/10.1038/sj.bjc.6602057.CrossRefPubMedPubMedCentral

66.

King, M. At risk drinking among general practice attenders: validation of the CAGE. Questionnaire. Psychol Med. 1986;16:213–217.CrossRefPubMed

67.

Deady M. A review of screening, assessment and outcome measures for drug and alcohol settings. Network of Alcohol and Other Drug Agencies; 2009. http://www.drugsandalcohol.ie/18266/1/NADA_A_Review_of_Screening%2C_Assessment_and_Outcome_Measures_for_Drug_and_Alcohol_Settings.pdf.

68.

Malet L, Schwan R, Boussiron D, Aublet-Cuvelier B, Llorca PM. Validity of the CAGE questionnaire in hospital. Eur Psychiatry. 2005;20(7):484–489. https://doi.org/10.1016/j.eurpsy.2004.06.027.CrossRefPubMed

69.

Wolford GL, Rosenberg SD, Drake RE, et al. Evaluation of methods for detecting substance use disorder in persons with severe mental illness. Psychol Addict Beh. 1999;13:313–326.CrossRef

70.

Brown RL, Rounds LA. Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice. Wis Med J. 1995;94(3):135–140.PubMed

71.

Dervaux A, Bayle FJ, Laqueille X, et al. Validity of the CAGE questionnaire in schizophrenic patients with alcohol abuse and dependence. Schizophr Res. 2006;81(2–3):151–155. https://doi.org/10.1016/j.schres.2005.09.012.CrossRefPubMed

72.

Brown RL, Leonard T, Saunders LA, Papasouliotis O. A two-item conjoint screen for alcohol and other drug problems. J Am Board Fam Pract. 2001;14(2):95–106.PubMed

73.

Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. A single-question screening test for drug use in primary care. Arch Intern Med. 2010;170(13):1155–1160. https://doi.org/10.1001/archinternmed.2010.140.CrossRefPubMedPubMedCentral

74.

Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. Primary care validation of a single-question alcohol screening test. J Gen Intern Med. 2009;24(7):783–788. https://doi.org/10.1007/s11606-009-0928-6.CrossRefPubMedPubMedCentral

75.

Hodgson R, Alwyn T, John B, Thom B, Smith A. The FAST Alcohol Screening Test. Alcohol. 2002;37(1):61–66.CrossRef

76.

Hodgson RJ, John B, Abbasi T, et al. Fast screening for alcohol misuse. Addict Behav. 2003;28(8):1453–1463.CrossRefPubMed

77.

Drinking levels defined. Available at: https://www.niaaa.nih.gov/alcohol-health/overview-alcohol-consumption/moderate-binge-drinking. Accessed Aug. 6, 2017.

78.

Smith PC, Cheng DM, Allensworth-Davies D, Winter MR, Saitz R. Use of a single alcohol screening question to identify other drug use. Drug Alcohol Depend. 2014;139:178–180. https://doi.org/10.1016/j.drugalcdep.2014.03.027.CrossRefPubMedPubMedCentral

79.

Liegl G, Wahl I, Berghofer A, et al. Using Patient Health Questionnaire-9 item parameters of a common metric resulted in similar depression scores compared to independent item response theory model reestimation. J Clin Epidemiol. 2016;71:25–34. https://doi.org/10.1016/j.jclinepi.2015.10.006 CrossRefPubMed

80.

McQuaid JR, Stein MB, McCahill M, Laffaye C, Ramel W. Use of brief psychiatric screening measures in a primary care sample. Depress Anxiety. 2000;12(1):21–29. https://doi.org/10.1002/1520-6394(2000)12:1<21::AID-DA3>3.0.CO;2-U.CrossRefPubMed

81.

National Quality Forum (2016). Measures database: depression utilization of the PHQ-9 tool (#0712). Available at: http://www.qualityforum.org/Measures_Reports_Tools.aspx. Accessed May 1, 2017.

82.

Mitchell AJ, Yadegarfar M, Gill J, Stubbs B. Case finding and screening clinical utility of the Patient Health Questionnaire (PHQ-9 and PHQ-2) for depression in primary care: a diagnostic meta-analysis of 40 studies. BJ Psych Open. 2016;2, 127–138.CrossRef

83.

U.S. Preventive Services Task Force. Draft recommendation statement: depression in adults: Screening. USPSTF, 2015. Available at:http://www.uspreventiveservicestaskforce.org/Page/Document/draft-recommendation-statement115/depression-in-adults-screening1. Accessed Aug. 6, 2017.

84.

Mitchell AJ, Meader N, Bird V, Rizzo M. Clinical recognition and recording of alcohol disorders by clinicians in primary and secondary care: meta-analysis. Br J Psychiatry. 2012;201:93–100. https://doi.org/10.1192/bjp.bp.110.091199.CrossRefPubMed

Titel: Screening for Behavioral Health Conditions in Primary Care Settings: A Systematic Review of the Literature
verfasst von: Norah Mulvaney-Day, PhD
Tina Marshall, PhD
Kathryn Downey Piscopo, PhD
Neil Korsen, MD, MS
Sean Lynch, PhD, LCSW
Lucy H. Karnell, PhD
Garrett E. Moran, PhD
Allen S. Daniels, EdD
Sushmita Shoma Ghose, PhD
Publikationsdatum: 25.09.2017
Verlag: Springer US
Erschienen in: Journal of General Internal Medicine / Ausgabe 3/2018
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-017-4181-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

23.04.2024 | Ablationstherapie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Screening for Behavioral Health Conditions in Primary Care Settings: A Systematic Review of the Literature

Abstract

Background

Methods

Results

Discussion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Drei Mythen bei der Antibiotikatherapie

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Background

Methods

Results

Discussion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Trends in Cannabis Use Disorder among Pregnant Women in the U.S., 1993–2014

Ethical Issues in the Design and Implementation of Population Health Programs

Overutilization of Breast Cancer Screening in the US: Awareness of a Growing Problem

Medicaid Expansion, Chronic Disease, and the Next Chapter of Health Reform

Massachusetts Medical Students Feel Unprepared to Treat Patients with Substance Use Disorder

High Adherence to HIV Pre-Exposure Prophylaxis among Veterans

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Drei Mythen bei der Antibiotikatherapie

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Update Innere Medizin